10-Q Filing

GUIDED THERAPEUTICS INC CIK: 924515 Q2 2015

Filing Information

Form Type	10-Q
Accession Number	`0001121781-15-000224`
Period End Date	20150630
Filing Date	20150813
Fiscal Year	2015
Fiscal Period	Q2
XBRL Instance	gthp-20150630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 94 Income Statement 80 Cash Flow Statement 72

Balance Sheet 94 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$76.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.97M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$78.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$485.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $78 and $76 at June 30, 2015 and December 31, 2014, respectively	`AccountsReceivableNet`	$338.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$144.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $78 and $76 at June 30, 2015 and December 31, 2014, respectively	`AccountsReceivableNet`	$282.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$110.00K	USD	Point-in-time
Inventory, net of reserves of $110 and $144, at June 30, 2015 and December 31, 2014, respectively	`InventoryNet`	$985.00K	USD	Point-in-time
Inventory, net of reserves of $110 and $144, at June 30, 2015 and December 31, 2014, respectively	`InventoryNet`	$1.18M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$28.00K	USD	Point-in-time
Series B convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Series B convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$99.00K	USD	Point-in-time
Series B convertible preferred stock shares authorized	`PreferredStockSharesAuthorized`	3.00	shares	Point-in-time
Series B convertible preferred stock shares authorized	`PreferredStockSharesAuthorized`	3.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.27M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.78M	USD	Point-in-time
Series B convertible preferred stock, Issued	`PreferredStockSharesIssued`	1.20	shares	Point-in-time
Series B convertible preferred stock, Issued	`PreferredStockSharesIssued`	1.20	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$444.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$587.00K	USD	Point-in-time
Series B convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding`	1.20	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$101.00K	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$90.00K	USD	Point-in-time
Series B convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding`	1.20	shares	Point-in-time
Debt issuance cost	`DeferredFinanceCostsNet`	$234.00K	USD	Point-in-time
Series C convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare1`	$0.00	USD	Point-in-time
Debt issuance cost	`DeferredFinanceCostsNet`	$564.00K	USD	Point-in-time
Series C convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare1`	-	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.25M	USD	Point-in-time
Series C convertible preferred stock shares authorized	`PreferredStockSharesAuthorized1`	7.20	shares	Point-in-time
Series C convertible preferred stock shares authorized	`PreferredStockSharesAuthorized1`	0.00	shares	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$768.00K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.03M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$4.04M	USD	Point-in-time
Series C convertible preferred stock, Issued	`PreferredStockSharesIssued1`	0.00	shares	Point-in-time
Series C convertible preferred stock, Issued	`PreferredStockSharesIssued1`	3.30	shares	Point-in-time
Series C convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding1`	3.30	shares	Point-in-time
Series C convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding1`	0.00	shares	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$646.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$681.00K	USD	Point-in-time
Notes payable past due	`OtherNotesPayable`	$172.00K	USD	Point-in-time
Notes payable past due	`OtherNotesPayable`	-	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	245,000.00	shares	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	195,000.00	shares	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	113,250.00	shares	Point-in-time
Current portion of long-term note payable	`ShortTermBorrowings`	$123.00K	USD	Point-in-time
Current portion of long-term note payable	`ShortTermBorrowings`	-	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	113,250.00	shares	Point-in-time
Short-term notes payable, net of discount	`NotesAndLoansPayableCurrent`	-	USD	Point-in-time
Short-term notes payable, net of discount	`NotesAndLoansPayableCurrent`	$1.06M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	96,889.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	96,889.00	shares	Point-in-time
Convertible note, net of discount	`ConvertibleNotesPayableCurrent`	$308.00K	USD	Point-in-time
Convertible note, net of discount	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.73M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.96M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.01M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.63M	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$24.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$36.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.79M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.60M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$2.07M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$956.00K	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$40.00K	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$1.03M	USD	Point-in-time
Convertible Debt, net of discount	`ConvertibleLongTermNotesPayable`	-	USD	Point-in-time
Convertible Debt, net of discount	`ConvertibleLongTermNotesPayable`	$783.00K	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$1.98M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$2.89M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$7.50M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$6.77M	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3 shares authorized, 1.2 shares issued and outstanding as of June 30, 2015 and December 31, 2014, (Liquidation preference of $1,200 at June 30, 2015 and December 31, 2014)	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$678.00K	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3 shares authorized, 1.2 shares issued and outstanding as of June 30, 2015 and December 31, 2014, (Liquidation preference of $1,200 at June 30, 2015 and December 31, 2014)	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$678.00K	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 7.2 shares authorized, 3.3 shares issued and outstanding as of June 30, 2015 and none at December 31, 2014, (Liquidation preference of $3,334 at June 30, 2015	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue1`	$935.00K	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 7.2 shares authorized, 3.3 shares issued and outstanding as of June 30, 2015 and none at December 31, 2014, (Liquidation preference of $3,334 at June 30, 2015	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue1`	-	USD	Point-in-time
Common stock, $.001 Par value; 245,000 shares authorized, 113,250 and 96,889 shares issued and outstanding as of June 30, 2015 and December 31, 2014	`CommonStockValue`	$97.00K	USD	Point-in-time
Common stock, $.001 Par value; 245,000 shares authorized, 113,250 and 96,889 shares issued and outstanding as of June 30, 2015 and December 31, 2014	`CommonStockValue`	$112.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$107.95M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$113.01M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-113.06M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-117.34M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.74M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.46M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.03M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$4.04M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Sales - devices and disposables	`SalesDevicesAndDisposables`	$103.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$323.00K	USD	2 Qtrs
Sales - devices and disposables	`SalesDevicesAndDisposables`	$201.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$229.00K	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$314.00K	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$463.00K	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$271.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$207.00K	USD	1 Quarter
Gross Loss	`GrossProfit`	$-104.00K	USD	1 Quarter
Gross Loss	`GrossProfit`	$-85.00K	USD	2 Qtrs
Gross Loss	`GrossProfit`	$-140.00K	USD	2 Qtrs
Gross Loss	`GrossProfit`	$-70.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$30.00K	USD	2 Qtrs
Contract and grant revenue	`Revenues`	$10.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$25.00K	USD	2 Qtrs
Contract and grant revenue	`Revenues`	$11.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$677.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.23M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$624.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$305.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$183.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$355.00K	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$345.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$628.00K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.02M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.14M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$999.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.98M	USD	2 Qtrs
Total	`OperatingExpenses`	$3.01M	USD	2 Qtrs
Total	`OperatingExpenses`	$4.00M	USD	2 Qtrs
Total	`OperatingExpenses`	$1.97M	USD	1 Quarter
Total	`OperatingExpenses`	$1.51M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.11M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.07M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.03M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.60M	USD	1 Quarter
OTHER INCOME	`OtherIncome`	$3.00K	USD	1 Quarter
OTHER INCOME	`OtherIncome`	$290.00K	USD	2 Qtrs
OTHER INCOME	`OtherIncome`	$284.00K	USD	1 Quarter
OTHER INCOME	`OtherIncome`	$5.00K	USD	2 Qtrs
INTEREST EXPENSE	`InterestExpense`	$815.00K	USD	2 Qtrs
INTEREST EXPENSE	`InterestExpense`	$47.00K	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$74.00K	USD	2 Qtrs
INTEREST EXPENSE	`InterestExpense`	$323.00K	USD	1 Quarter
CHANGES IN FAIR VALUE OF WARRANTS	`DerivativeGainLossOnDerivativeNet1`	$-66.00K	USD	1 Quarter
CHANGES IN FAIR VALUE OF WARRANTS	`DerivativeGainLossOnDerivativeNet1`	$-81.00K	USD	1 Quarter
CHANGES IN FAIR VALUE OF WARRANTS	`DerivativeGainLossOnDerivativeNet1`	$648.00K	USD	2 Qtrs
CHANGES IN FAIR VALUE OF WARRANTS	`DerivativeGainLossOnDerivativeNet1`	$461.00K	USD	2 Qtrs
TOTAL OTHER INCOME	`OtherNonoperatingIncome`	$-125.00K	USD	1 Quarter
TOTAL OTHER INCOME	`OtherNonoperatingIncome`	$392.00K	USD	2 Qtrs
TOTAL OTHER INCOME	`OtherNonoperatingIncome`	$123.00K	USD	2 Qtrs
TOTAL OTHER INCOME	`OtherNonoperatingIncome`	$-105.00K	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.71M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.71M	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.15M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.95M	USD	2 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	2 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-1.71M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-3.71M	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-2.95M	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-2.15M	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-41.00K	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-1.29M	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-1.33M	USD	2 Qtrs
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-89.00K	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.00M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.28M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.19M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.80M	USD	2 Qtrs
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	2 Qtrs
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	2 Qtrs
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	102,326.00	shares	2 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	107,256.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	72,986.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	72,223.00	shares	2 Qtrs

Cash Flow Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.71M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.95M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.15M	USD	1 Quarter
Bad debt expense	`BadDebtExpense`	-	USD	2 Qtrs
Bad debt expense	`BadDebtExpense`	$-22.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$144.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$235.00K	USD	2 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$543.00K	USD	2 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$65.00K	USD	2 Qtrs
Stock based compensation	`ShareBasedCompensation`	$529.00K	USD	2 Qtrs
Stock based compensation	`ShareBasedCompensation`	$546.00K	USD	2 Qtrs
Change in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$496.00K	USD	2 Qtrs
Change in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$648.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$74.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-194.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$100.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-56.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-88.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-73.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-13.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-10.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$231.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$172.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$12.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$14.00K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$257.00K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$613.00K	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$890.00K	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$1.76M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-2.82M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-1.19M	USD	2 Qtrs
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	2 Qtrs
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$119.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-119.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$2.03M	USD	2 Qtrs
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	2 Qtrs
Net proceeds from issuance of common stock and warrants	`ProceedsFromIssuanceOfCommonStock`	$720.00K	USD	2 Qtrs
Net proceeds from issuance of common stock and warrants	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from debt financing, net of issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$203.00K	USD	2 Qtrs
Proceeds from debt financing, net of issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$3.19M	USD	2 Qtrs
Payments made on notes payable	`RepaymentsOfNotesPayable`	$91.00K	USD	2 Qtrs
Payments made on notes payable	`RepaymentsOfNotesPayable`	$446.00K	USD	2 Qtrs
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$67.00K	USD	2 Qtrs
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$141.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.01M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.81M	USD	2 Qtrs
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.81M	USD	2 Qtrs
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-128.00K	USD	2 Qtrs
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.97M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$485.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.97M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$485.00K	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$20.00K	USD	2 Qtrs
Cash paid for Interest	`InterestPaid`	$56.00K	USD	2 Qtrs
Deemed dividend on beneficial conversion feature of Series C preferred stock	`DeemedDividendOnBeneficialConversionFeatureOfSeriesCPreferredStock`	$148.00K	USD	2 Qtrs
Deemed dividend on beneficial conversion feature of Series C preferred stock	`DeemedDividendOnBeneficialConversionFeatureOfSeriesCPreferredStock`	-	USD	2 Qtrs
Deemed dividend on price changes for Series B preferred stock warrants	`DeemedDividendOnPriceChangesForSeriesBPreferredStockWarrants`	$72.00K	USD	2 Qtrs
Deemed dividend on price changes for Series B preferred stock warrants	`DeemedDividendOnPriceChangesForSeriesBPreferredStockWarrants`	-	USD	2 Qtrs
Deemed dividend on December 2014 public offering warrants	`DeemedDividendOnDecember2014PublicOfferingWarrants`	$1.04M	USD	2 Qtrs
Deemed dividend on December 2014 public offering warrants	`DeemedDividendOnDecember2014PublicOfferingWarrants`	-	USD	2 Qtrs
Term changes on Series B preferred stock and December 2014 public offering warrants resulting in transfer to equity	`TermChangesOnSeriesBPreferredStockAndDecember2014PublicOfferingWarrantsResultingInTransferToEquity`	-	USD	2 Qtrs
Term changes on Series B preferred stock and December 2014 public offering warrants resulting in transfer to equity	`TermChangesOnSeriesBPreferredStockAndDecember2014PublicOfferingWarrantsResultingInTransferToEquity`	$1.41M	USD	2 Qtrs
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$66.00K	USD	2 Qtrs
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$833.00K	USD	2 Qtrs
Dividends on preferred stock	`DeemedDividendsOnPreferredStock`	$64.00K	USD	2 Qtrs
Dividends on preferred stock	`DeemedDividendsOnPreferredStock`	$89.00K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.